McKesson Corporation is a leading global healthcare services company that provides pharmaceutical distribution, medical-surgical supply logistics, and healthcare technology solutions. The company serves as a critical link in the healthcare supply chain, connecting biopharmaceutical manufacturers and medical suppliers with pharmacies, hospitals, and physician practices to improve patient outcomes and operational efficiency.
Based on Q1 2026 · FQ4 FY2026 filing
Distributes branded, generic, specialty, and over-the-counter pharmaceutical drugs and healthcare-related products across the United States. It also provides practice management, clinical support, and business solutions to specialty practices, including oncology.
McKesson Connect, Health Mart, Health Mart Atlas, McKesson SynerGx, Central Fill, McKesson OneStop Generics, McKesson Reimbursement Advantage
Retail national accounts, Community pharmacies, Hospitals, Oncology practices, Health systems
Provides medical-surgical supply distribution, logistics, and biomedical maintenance services to healthcare providers across the alternate-site spectrum. The company announced an intention to separate this segment into an independent company in 2025.
McKesson Brand medical supplies, Gloves, Needles, Syringes, Infusion pumps, Laboratory equipment
Physician offices, Surgery centers, Nursing homes, Home health care agencies
Connects patients, pharmacies, providers, and biopharma companies to address medication access, affordability, and adherence challenges. The segment provides technology-driven services such as electronic prior authorization and prescription price transparency.
Electronic prior authorization, Prescription price transparency, Benefit insight, Dispensing support services
Biopharma companies, Pharmacy benefit managers, Health plans, Providers
Operates pharmaceutical wholesale and retail distribution businesses in Canada and Norway. This segment provides automation, technology solutions, and specialty health services to retail and hospital customers in these markets.
IDA, Guardian, The Medicine Shoppe, Remedy’sRx, INVIVA infusion clinics, PDCI consultancy
Retail pharmacies, Institutional customers, Wholesale customers, Canadian provincial governments
McKesson is one of the largest pharmaceutical distributors in North America, leveraging massive scale and a diversified portfolio of technology and clinical services to maintain a leading market position.
United States, Canada, Norway
Pharmacies, Hospitals, Biopharmaceutical manufacturers, Physician practices
Pharmaceutical manufacturers, Medical-surgical equipment manufacturers, Generic drug producers, Biotechnology firms
Retail pharmacy chains, Independent pharmacies, Hospitals and health systems, Specialty clinics, Government healthcare agencies
Cencora
COR
Primary competitor in pharmaceutical distribution and wholesaling
Cardinal Health
CAH
Primary competitor in pharmaceutical and medical-surgical distribution
Medline, Inc.
MDLN
Major medical-surgical product distributor
Viatris
VTRS
Large customer that also exerts significant supply chain pressure
AbbVie
ABBV
Major wholesale distributor (customer/partner context)
Eli Lilly
LLY
Major distributor (also listed as a customer)
Walmart
WMT
Joint venture partner in ClarusONE Sourcing Services for generic drug procurement
CVS Health
CVS
Largest pharmaceutical distribution customer
Centers for Disease Control and Prevention (CDC)
Exclusive distributor for the Vaccines for Children program
The US Oncology Network
Network of integrated community-based oncology practices
Ontada
Oncology technology and insights business
SCRI Oncology, LLC
Oncology research business (51% controlling interest)
MacroHelix
340B program management software provider
Common questions about McKesson
McKesson Corporation is a leading global healthcare services company that provides pharmaceutical distribution, medical-surgical supply logistics, and healthcare technology solutions. The company serves as a critical link in the healthcare supply chain, connecting biopharmaceutical manufacturers and medical suppliers with pharmacies, hospitals, and physician practices to improve patient outcomes and operational efficiency.
McKesson (MCK) has a market capitalization of $93.3B and trades on NYSE.
McKesson generated $403.43B in trailing twelve-month revenue with net income of $4.8B, representing a net margin of 1.2%. Gross margin stands at 3.6%, with free cash flow of $5.7B. These figures are based on the Q1 2026 filing.
McKesson's key competitors include Cencora, Inc., Cardinal Health, Inc., Medline Inc. Class A common stock, and others. These companies compete in similar markets and product categories.
McKesson has approximately 51,000 employees.